42 Lotronex PPTs View free & download

Lotronex - Prescribe only to patients in whom the benefits exceed the risks. Appropriate inclusion criteria ... Lotronex prescribed only by physicians: ...

Prescribe only to patients in whom the benefits exceed the risks. Appropriate inclusion criteria ... Lotronex prescribed only by physicians: ...

| PowerPoint PPT presentation | free to view

Lotronex - Colonoscopy: Confirmed Ischemic colitis. 10. Lotronex and ... Colonoscopy-patchy, friable, ischemic or hyperemic, edematous mucosa with erosions that later ...

Colonoscopy: Confirmed Ischemic colitis. 10. Lotronex and ... Colonoscopy-patchy, friable, ischemic or hyperemic, edematous mucosa with erosions that later ...

| PowerPoint PPT presentation | free to view

Risk Management Program for Lotronex PowerPoint PPT Presentation

Risk Management Program for Lotronex - ... US Regulatory Affairs. GlaxoSmithKline. A 2 ... disability or restriction of daily activities due to IBS ... National Boards of State Pharmacists Newsletters ...

... US Regulatory Affairs. GlaxoSmithKline. A 2 ... disability or restriction of daily activities due to IBS ... National Boards of State Pharmacists Newsletters ...

| PowerPoint PPT presentation | free to view

LOTRONEX alosetron HCl Tablets: PowerPoint PPT Presentation

LOTRONEX alosetron HCl Tablets: - Frequent and severe abdominal pain/discomfort. Frequent bowel urgency or fecal incontinence ... Rate of Adequate Relief of IBS Pain and Discomfort ...

Frequent and severe abdominal pain/discomfort. Frequent bowel urgency or fecal incontinence ... Rate of Adequate Relief of IBS Pain and Discomfort ...

| PowerPoint PPT presentation | free to view

LOTRONEX FDA Gastrointestinal Drugs Advisory Committee PowerPoint PPT Presentation

LOTRONEX FDA Gastrointestinal Drugs Advisory Committee - Unanimous approval at November 16, 1999 FDA GI Drugs Advisory Committee ... Tailored communication plan. A 9. Alosetron 2000 6/26. Glaxo Wellcome Presentation: AGENDA ...

Unanimous approval at November 16, 1999 FDA GI Drugs Advisory Committee ... Tailored communication plan. A 9. Alosetron 2000 6/26. Glaxo Wellcome Presentation: AGENDA ...

| PowerPoint PPT presentation | free to view

J'S' Hull - Sample packets/Starter kits for patients. Appropriate ... Starter kit distributed by physician to patients prescribed Lotronex ... Patient Starter Kit: Phase I ...

Sample packets/Starter kits for patients. Appropriate ... Starter kit distributed by physician to patients prescribed Lotronex ... Patient Starter Kit: Phase I ...

| PowerPoint PPT presentation | free to view

Elizabeth B. Andrews, Ph.D., M.P.H. PowerPoint PPT Presentation

Elizabeth B. Andrews, Ph.D., M.P.H. - Title: Core set Author: stj11454 Last modified by: CDER USER Created Date: 7/20/1998 2:36:45 PM Document presentation format: On-screen Show Other titles

Title: Core set Author: stj11454 Last modified by: CDER USER Created Date: 7/20/1998 2:36:45 PM Document presentation format: On-screen Show Other titles

| PowerPoint PPT presentation | free to view

Financial%20Conflicts%20of%20Interest:%20The%20Limits%20of%20Disclosure%20and%20Management PowerPoint PPT Presentation

Financial%20Conflicts%20of%20Interest:%20The%20Limits%20of%20Disclosure%20and%20Management - 42 Randomized Trials of Natural and Synthetic Surfactant in the Treatment of Neonatal Respiratory Distress Syndrome.

42 Randomized Trials of Natural and Synthetic Surfactant in the Treatment of Neonatal Respiratory Distress Syndrome.

| PowerPoint PPT presentation | free to download

Recent Withdrawals PowerPoint PPT Presentation

Recent Withdrawals - Title: Developing Consumer Marketing Claims within the Clinical Development Process Author: Lou Morris Created Date: 9/29/2000 3:30:09 PM Document presentation format

Title: Developing Consumer Marketing Claims within the Clinical Development Process Author: Lou Morris Created Date: 9/29/2000 3:30:09 PM Document presentation format

| PowerPoint PPT presentation | free to download

Developing a RiskMAP PowerPoint PPT Presentation

Developing a RiskMAP - promotional techniques to publicize risk management (e.g., ... alternative therapy available and reversibility of adverse events preventability of the adverse event, ...

promotional techniques to publicize risk management (e.g., ... alternative therapy available and reversibility of adverse events preventability of the adverse event, ...

| PowerPoint PPT presentation | free to download

How Big Pharma Should Change PowerPoint PPT Presentation

How Big Pharma Should Change - How Big Pharma Should Change. Peter Lurie, MD, MPH. Health ... Lexapro (escitalopram) Redux (dexfenfluramine) Over-the-Counter Pediatric. Cough/Cold Remedies ...

How Big Pharma Should Change. Peter Lurie, MD, MPH. Health ... Lexapro (escitalopram) Redux (dexfenfluramine) Over-the-Counter Pediatric. Cough/Cold Remedies ...

| PowerPoint PPT presentation | free to download

Irritable Bowel Syndrome PowerPoint PPT Presentation

Irritable Bowel Syndrome - Irritable Bowel Syndrome Jennifer E. Guss, MD Baylor College of Medicine Med-Peds Continuity Clinic IBS:Definition Syndrome characterized by chronic abdominal pain ...

Irritable Bowel Syndrome Jennifer E. Guss, MD Baylor College of Medicine Med-Peds Continuity Clinic IBS:Definition Syndrome characterized by chronic abdominal pain ...

| PowerPoint PPT presentation | free to view

An Evaluation of the Impact of REMS on spontaneous reporting for marketed products PowerPoint PPT Presentation

An Evaluation of the Impact of REMS on spontaneous reporting for marketed products - Data collection: Search the FDA AERS database using WebVDME (Lincoln Technologies, Inc. ... Rate (cases/yr) 236. 235. 1.00 (p 0.05) ...

Data collection: Search the FDA AERS database using WebVDME (Lincoln Technologies, Inc. ... Rate (cases/yr) 236. 235. 1.00 (p 0.05) ...

| PowerPoint PPT presentation | free to view

Risk%20Management%20Strategy%20for%20the%20Pharma%20and%20Biotech%20Product%20Lifecycle:%20New%20Regulatory%20and%20Legal%20Focus%20and%20Approach - Risk Management Strategy for the Pharma and Biotech Product Lifecycle: ... New FDA Guidance documents on risk management programs ...

Risk Management Strategy for the Pharma and Biotech Product Lifecycle: ... New FDA Guidance documents on risk management programs ...

| PowerPoint PPT presentation | free to download

Inflammatory Bowel Disease, Diverticulitis, and Inflammatory Bowel Disease PowerPoint PPT Presentation

Inflammatory Bowel Disease, Diverticulitis, and Inflammatory Bowel Disease - Inflammatory Bowel Disease, ... Document presentation format: On ... Diverticulitis Diverticulitis Diverticular Disease Case Inflammatory Bowel Disease IBD ...

Inflammatory Bowel Disease, ... Document presentation format: On ... Diverticulitis Diverticulitis Diverticular Disease Case Inflammatory Bowel Disease IBD ...

| PowerPoint PPT presentation | free to view

PROKINETIC AGENTS, ANTIEMETICS, PowerPoint PPT Presentation

PROKINETIC AGENTS, ANTIEMETICS, - IBS is one of the most common disorders that doctors see. ... IBS is a syndrome because it can cause a group of ... will diagnose IBS based on your symptoms. ...

IBS is one of the most common disorders that doctors see. ... IBS is a syndrome because it can cause a group of ... will diagnose IBS based on your symptoms. ...

| PowerPoint PPT presentation | free to view

Developing, Pilot Testing PowerPoint PPT Presentation

Developing, Pilot Testing - Target key groups most likely to be able to minimize risk ... Market research data. Competitive products. Physician prescribing behavior ...

Target key groups most likely to be able to minimize risk ... Market research data. Competitive products. Physician prescribing behavior ...

| PowerPoint PPT presentation | free to download

Developing a RiskMAP - promotional techniques to publicize risk management (e.g., ... alternative therapy available and reversibility of adverse events preventability of the adverse event, ...

promotional techniques to publicize risk management (e.g., ... alternative therapy available and reversibility of adverse events preventability of the adverse event, ...

| PowerPoint PPT presentation | free to download

Distinguishing Diarrheas: searching for an association between Giardia lamblia and irritable bowel s PowerPoint PPT Presentation

Distinguishing Diarrheas: searching for an association between Giardia lamblia and irritable bowel s - Distinguishing Diarrheas: searching for an association between Giardia lamblia ... bowel syndrome and dyspepsia Grazioli et al. World Journal of Gastroenterology ...

Distinguishing Diarrheas: searching for an association between Giardia lamblia ... bowel syndrome and dyspepsia Grazioli et al. World Journal of Gastroenterology ...

| PowerPoint PPT presentation | free to view

The Tissue Industry PowerPoint PPT Presentation

The Tissue Industry - Brian's Tragedy. 12/22/77 11/11/01. Elective Knee Surgery 11/7/01. Death three ... CDC Proves Cryolife Is Responsible For Brian's Death and Recommends Changes ...

Brian's Tragedy. 12/22/77 11/11/01. Elective Knee Surgery 11/7/01. Death three ... CDC Proves Cryolife Is Responsible For Brian's Death and Recommends Changes ...

| PowerPoint PPT presentation | free to download

Risk Management Planning Industry Experience in Implementation PowerPoint PPT Presentation

Risk Management Planning Industry Experience in Implementation - 1. Risk Management Planning. Industry Experience in ... EU QPPV Executive, Eli Lilly. 2. Risk Management A Sense of D j Vu? 'I am convinced that .

1. Risk Management Planning. Industry Experience in ... EU QPPV Executive, Eli Lilly. 2. Risk Management A Sense of D j Vu? 'I am convinced that .

| PowerPoint PPT presentation | free to download

Acute Abdominal Pain Lower GI Problems PowerPoint PPT Presentation

Acute Abdominal Pain Lower GI Problems - Acute Abdominal Pain Lower GI Problems Module 2 Acute Abdominal Pain Etiology Inflammation Crohn s Appendicitis Cholecysitis Colitis, etc. Vascular Aneurysm ...

Acute Abdominal Pain Lower GI Problems Module 2 Acute Abdominal Pain Etiology Inflammation Crohn s Appendicitis Cholecysitis Colitis, etc. Vascular Aneurysm ...

| PowerPoint PPT presentation | free to view

Drugs Affecting the Gastrointestinal System and Nutrition PowerPoint PPT Presentation

Drugs Affecting the Gastrointestinal System and Nutrition - Drugs Affecting the Gastrointestinal System and Nutrition Jan Bazner-Chandler MSN, CNS, RN, CPNP Acid-related Pathophysiology Hydrochloric acid (HCL) aids in ...

Drugs Affecting the Gastrointestinal System and Nutrition Jan Bazner-Chandler MSN, CNS, RN, CPNP Acid-related Pathophysiology Hydrochloric acid (HCL) aids in ...

| PowerPoint PPT presentation | free to view

Pharmacoepidemiology: What Happens After Approval PowerPoint PPT Presentation

Pharmacoepidemiology: What Happens After Approval - ... of the use of and the effects of drugs in large numbers of people' -B. Strom ... Non-steroidal Anti-inflammatory Drugs and the Risk of Alzheimer's Disease ' ...

... of the use of and the effects of drugs in large numbers of people' -B. Strom ... Non-steroidal Anti-inflammatory Drugs and the Risk of Alzheimer's Disease ' ...

| PowerPoint PPT presentation | free to view

Developing Risk Management Systems that meet FDA rules and dont hurt your product PowerPoint PPT Presentation

Developing Risk Management Systems that meet FDA rules and dont hurt your product - articipants should appreciate strategic and tactical elements for developing a ... used according to label instructions' [Janet Woodcock, Temple University, 4/4/00] ...

articipants should appreciate strategic and tactical elements for developing a ... used according to label instructions' [Janet Woodcock, Temple University, 4/4/00] ...

| PowerPoint PPT presentation | free to view

Considerations for the Use of Risk Minimization Action Plans FDA Draft Guidance and Experience PowerPoint PPT Presentation

Considerations for the Use of Risk Minimization Action Plans FDA Draft Guidance and Experience - Patient Package Inserts (PPI) 22. Medication Guides. FDA approved patient labeling ... Patient Package Insert (PPI) ... Pkg insert: Boxed warning, 2nd line indication ...

Patient Package Inserts (PPI) 22. Medication Guides. FDA approved patient labeling ... Patient Package Insert (PPI) ... Pkg insert: Boxed warning, 2nd line indication ...

| PowerPoint PPT presentation | free to view

Hypnosis and Irritable Bowel Syndrome - Hypnosis and Irritable Bowel Syndrome

Hypnosis and Irritable Bowel Syndrome

| PowerPoint PPT presentation | free to view

GI DRUGS - gi drugs antidiarrheals laxatives antiemetics drugs for inflammatory bowel disease. treatment of irritable bowel syndrome gi motility and secretion colonic function ...

gi drugs antidiarrheals laxatives antiemetics drugs for inflammatory bowel disease. treatment of irritable bowel syndrome gi motility and secretion colonic function ...

| PowerPoint PPT presentation | free to download

Considerations for the Use of Risk Minimization Action Plans FDA Draft Guidance and Experience - Goal End result, expressed in terms of one or more health outcomes to be achieved (or avoided) ... products with Medication guides, CME. Reminder systems ...

Goal End result, expressed in terms of one or more health outcomes to be achieved (or avoided) ... products with Medication guides, CME. Reminder systems ...

| PowerPoint PPT presentation | free to download

CB1 - 5. Damon H, et al. Gastroenterol Clin Biol. ... 1. Thompson WG, et al. Gut 1999; 45 (Suppl II): II43-II47. Addendum to SCE T 2-7. 43 ...

5. Damon H, et al. Gastroenterol Clin Biol. ... 1. Thompson WG, et al. Gut 1999; 45 (Suppl II): II43-II47. Addendum to SCE T 2-7. 43 ...

| PowerPoint PPT presentation | free to view

Updates on the use of biologic therapies in AS PowerPoint PPT Presentation

Updates on the use of biologic therapies in AS - Exclusion: ankylosis prior anti-TNF. Other: stable NSAIDS/DMARDS and prednisone ... Effect of biologics on established ankylosis/ and on disease progression ? ...

Exclusion: ankylosis prior anti-TNF. Other: stable NSAIDS/DMARDS and prednisone ... Effect of biologics on established ankylosis/ and on disease progression ? ...

| PowerPoint PPT presentation | free to view

Developing Risk Management Systems that meet FDA rules ---and don PowerPoint PPT Presentation

Developing Risk Management Systems that meet FDA rules ---and don - Title: Developing Consumer Marketing Claims within the Clinical Development Process Author: Lou Morris Last modified by: Lou Created Date: 9/29/2000 3:30:09 PM

Title: Developing Consumer Marketing Claims within the Clinical Development Process Author: Lou Morris Last modified by: Lou Created Date: 9/29/2000 3:30:09 PM

| PowerPoint PPT presentation | free to download

Gastroenterology - Gastroenterology

Gastroenterology

| PowerPoint PPT presentation | free to download

A MultiHeaded Hydra Turned Medicine into Snake Oil Vera Sharav Alliance for Human Research Protectio PowerPoint PPT Presentation

A MultiHeaded Hydra Turned Medicine into Snake Oil Vera Sharav Alliance for Human Research Protectio - Dr. Bruce Pollack (U. Pitts) signed it. The Journal of Clinical ... David Willis, M.D., Medical Director, NW Institute. Pediatric News, January, 2004 ...

Dr. Bruce Pollack (U. Pitts) signed it. The Journal of Clinical ... David Willis, M.D., Medical Director, NW Institute. Pediatric News, January, 2004 ...

| PowerPoint PPT presentation | free to view

www'alizyme'com LSE:AZM PowerPoint PPT Presentation

www'alizyme'com LSE:AZM - This presentation has been organised by Alizyme plc (the 'Company') in order to ... glassy amylose. ethylcellulose. Not digested by human amylases ...

This presentation has been organised by Alizyme plc (the 'Company') in order to ... glassy amylose. ethylcellulose. Not digested by human amylases ...

| PowerPoint PPT presentation | free to view

The U.S. Approach to Risk Management PowerPoint PPT Presentation

The U.S. Approach to Risk Management - The most significant amendments to the Federal Food, Drug, and Cosmetic Act ... (NDAs), Biologic License Applications (BLAs), Abbreviated New Drug Applications ...

The most significant amendments to the Federal Food, Drug, and Cosmetic Act ... (NDAs), Biologic License Applications (BLAs), Abbreviated New Drug Applications ...

| PowerPoint PPT presentation | free to download

Monitoring the Safety of FDAApproved Drugs: A Legislative Review PowerPoint PPT Presentation

Monitoring the Safety of FDAApproved Drugs: A Legislative Review - For the FDA, this will require a continuous availability of new data and ongoing, ... FDA estimates 8 year time-span for entire process ...

For the FDA, this will require a continuous availability of new data and ongoing, ... FDA estimates 8 year time-span for entire process ...

| PowerPoint PPT presentation | free to view

The new frontier of information cocreation PowerPoint PPT Presentation

The new frontier of information cocreation - Industry mergers put some news organizations at an economic disadvantage ... News organization works with business/advertiser to create a landing page to ...

Industry mergers put some news organizations at an economic disadvantage ... News organization works with business/advertiser to create a landing page to ...

| PowerPoint PPT presentation | free to view

Bad Digestion PowerPoint PPT Presentation

Bad Digestion - Bad Digestion By Dr. Joel Doughten ABDOMINAL PAIN PROGNOSIS Dyspepsia is typically a relapsing condition. In studies, 60 to 90 percent of people continue to have ...

Bad Digestion By Dr. Joel Doughten ABDOMINAL PAIN PROGNOSIS Dyspepsia is typically a relapsing condition. In studies, 60 to 90 percent of people continue to have ...

| PowerPoint PPT presentation | free to download

- The FDA: Watchdog Without a Bite (and With No Incentive to Bark) Joe Lex, MD, FAAEM Temple University School of Medicine Philadelphia, PA Joseph.Lex@TUHS.Temple.edu

The FDA: Watchdog Without a Bite (and With No Incentive to Bark) Joe Lex, MD, FAAEM Temple University School of Medicine Philadelphia, PA Joseph.Lex@TUHS.Temple.edu

| PowerPoint PPT presentation | free to download

The Pharmaceutical Industry Martin Donohoe, MD, FACP - Pharmaceutical Industry Martin Donohoe, MD, FACP The Pharmaceutical Industry Outline Economics drug costs drug development Research Marketing Drug Regulation/The FDA ...

Pharmaceutical Industry Martin Donohoe, MD, FACP The Pharmaceutical Industry Outline Economics drug costs drug development Research Marketing Drug Regulation/The FDA ...

The Pharmaceutical Industry Martin Donohoe, MD, FACP - Bush/Congressional prescription drug benefit proposals woefully inadequate ... 2001 California Medicare Prescription Drug Discount Program ...

Bush/Congressional prescription drug benefit proposals woefully inadequate ... 2001 California Medicare Prescription Drug Discount Program ...

Lotronex PowerPoint PPT Presentations